☆ 4.6 Article

Advances in long non-coding RNA regulating drug resistance of cancer

GENE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, Research & Experimental

Lycorine weakens tamoxifen resistance of breast cancer via abrogating HAGLR-mediated epigenetic suppression on VGLL4 by DNMT1

Jing Zhai et al.

Summary: This study investigated the role of lycorine, a natural alkaloid, in regulating tamoxifen resistance in breast cancer. The results showed that lycorine reduced tamoxifen resistance in breast cancer cells and increased drug-induced apoptosis. Mechanistically, lycorine modulated the expression of HAGLR and VGLL4 genes, which are involved in the resistance to tamoxifen. Overall, lycorine plays a crucial role in improving the effectiveness of tamoxifen treatment for breast cancer.

KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Downregulation of LncRNA SNHG7 Sensitizes Colorectal Cancer Cells to Resist Anlotinib by Regulating miR-181a-5p/GATA6

Deng Pan et al.

Gastroenterology Research and Practice (2023)

添加到收藏夹

Article Chemistry, Medicinal

LncRNA SNHG6 Upregulates KPNA5 to Overcome Gemcitabine Resistance in Pancreatic Cancer via Sponging miR-944

Ge Gao et al.

Summary: Our study shows that the downregulation of LncRNA SNHG6 is correlated with poor prognosis in pancreatic cancer patients. We demonstrate that SNHG6 can sponge miR-944 and upregulate the target gene KPNA5, resulting in suppression of cancer cell proliferation and increased sensitivity to GEM treatment in GEM-resistant pancreatic cancer cells. Moreover, we find that higher expression of KPNA5 is associated with GEM non-resistance in patients. In summary, our findings suggest that targeting the SNHG6/miR944/KPNA5 axis may enhance the efficacy of GEM treatment in pancreatic cancer.

PHARMACEUTICALS (2023)

添加到收藏夹

Article Cell Biology

LncRNA FALEC increases the proliferation, migration and drug resistance of cholangiocarcinoma through competitive regulation of miR-20a-5p/SHOC2 axis

Haiming Du et al.

Aging-US (2023)

添加到收藏夹

Article Biotechnology & Applied Microbiology

LncRNA-NEF suppressed oxaliplatin resistance and epithelial-mesenchymal transition in colorectal cancer through epigenetically inactivating MEK/ERK signaling

Chuan-Jian Shi et al.

Summary: Acquired epithelial-mesenchymal transition is a major cause of oxaliplatin chemoresistance in colorectal cancer (CRC). In this study, it was found that lncRNA Neighboring Enhancer of FOXA2 (lncRNA-NEF) was down-regulated in an oxaliplatin-resistant CRC cell line. Further studies showed that lncRNA-NEF suppressed oxaliplatin resistance and epithelial-mesenchymal transition both in vitro and in vivo by promoting the expression of DOK1 and inhibiting the MEK/ERK signaling pathway. This research reveals the critical role of lncRNA-NEF in mediating oxaliplatin chemotherapy resistance in CRC and suggests a potential therapeutic strategy for CRC patients with oxaliplatin resistance.

CANCER GENE THERAPY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Transcription factor B-MYB activates lncRNA CCAT1 and upregulates SOCS3 to promote chemoresistance in colorectal cancer

Feng Liu et al.

Summary: According to bioinformatic analysis and experimental verification, both long non-coding RNA CCAT1 and upstream gene B-MYB are overexpressed in colorectal cancer (CRC) cells. It was found that CCAT1 promotes the resistance of CRC cells to oxaliplatin (OXA) by activating B-MYB, which further recruits DNMT1 to inhibit the expression of SOCS3, leading to increased resistance to OXA. These findings suggest that B-MYB may promote chemoresistance of CRC cells to OXA through the CCAT1/DNMT1/SOCS3 axis.

CHEMICO-BIOLOGICAL INTERACTIONS (2023)

添加到收藏夹

Article Oncology

Extracellular Vesicle-Mediated Transfer of LncRNA IGFL2-AS1 Confers Sunitinib Resistance in Renal Cell Carcinoma

Yihui Pan et al.

Summary: The long noncoding RNA IGFL2-AS1 drives therapy resistance in renal cell carcinoma by regulating TP53INP2-triggered autophagy, suggesting it as a potential therapeutic target for overcoming resistance.

CANCER RESEARCH (2023)

添加到收藏夹

Article Cell Biology

Repression of linc01555 up-regulates angiomotin-p130 via the microRNA-122-5p/clic1 axis to impact vasculogenic mimicry-mediated chemotherapy resistance in small cell lung cancer

Dan Li et al.

Summary: The study found that linc01555 may cause changes in DDP resistance in small cell lung cancer (SCLC) through the miR-122-5p/CLIC1 pathway. This finding may provide drug targets for SCLC resistance.

CELL CYCLE (2023)

添加到收藏夹

Article Genetics & Heredity

Exosomal lncRNA NEAT1 induces paclitaxel resistance in breast cancer cells and promotes cell migration by targeting miR-133b

Xinyu Wei et al.

Summary: This study found that lncRNA NEAT1 is highly expressed in BC cells and exosomes. NEAT1 promotes migration and paclitaxel resistance in BC cells, while downregulation of NEAT1 reduces drug resistance. In addition, downregulation of NEAT1 decreases migration and proliferation of BC cells by inhibiting CXCL12 expression and reducing miR-133b adsorption. This study reveals that exosomal lncRNA NEAT1 derived from SKBR3/PR cells in the tumor microenvironment can induce paclitaxel resistance, cell migration, and growth, and may serve as a new target for clinical treatment of BC.

GENE (2023)

添加到收藏夹

Article Toxicology

Silencing lncRNA HCG18 regulates GPX4-inhibited ferroptosis by adsorbing miR-450b-5p to avert sorafenib resistance in hepatocellular carcinoma

Xiaoming Li et al.

Summary: This study discusses the mechanism of GPX4-inhibited ferroptosis in sorafenib resistance in hepatocellular carcinoma. Silencing HCG18 can inhibit cell proliferation, promote apoptosis, and weaken sorafenib resistance. Furthermore, silencing HCG18 can promote GPX4-inhibited ferroptosis and reduce sorafenib resistance.

HUMAN & EXPERIMENTAL TOXICOLOGY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Development of Chromatin Immunoprecipitation for the Analysis of Histone Modifications in Red Macroalga Neopyropia yezoensis (Rhodophyta)

Shinnosuke Ueda et al.

Summary: A ChIP method with modifications has been developed in the red macroalga Neopyropia yezoensis, enabling the identification of histone marks in generation-specific genes. The results show that the acetylation of histone H3 remains relatively high even in generation-repressed gene expression.

MOLECULAR BIOTECHNOLOGY (2023)

添加到收藏夹

Article Oncology

Exosomal lincROR Promotes Docetaxel Resistance in Prostate Cancer through a beta-catenin/HIF1 alpha Positive Feedback Loop

Xingkang Jiang et al.

Summary: This study revealed that lincROR is highly expressed in DTX-resistant prostate cancer and promotes cancer cell growth and DTX resistance. lincROR interacts with MYH9 protein and activates the β-catenin/HIF1a positive feedback loop. Additionally, lincROR can be packaged into exosomes and transferred to recipient cells to confer chemoresistance.

MOLECULAR CANCER RESEARCH (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

LncRNA CACClnc promotes chemoresistance of colorectal cancer by modulating alternative splicing of RAD51

Xinyu Zhang et al.

Summary: In this study, a novel upregulated long non-coding RNA (lncRNA) called CACClnc was identified, which was associated with chemoresistance and poor prognosis in colorectal cancer (CRC). The study revealed that CACClnc promoted CRC resistance to chemotherapy by enhancing DNA repair and homologous recombination. The expression of exosomal CACClnc in peripheral plasma of CRC patients was also found to effectively predict the chemotherapy effect prior to treatment. Therefore, targeting CACClnc and its associated pathway could provide valuable insight into clinical management and potentially improve outcomes for CRC patients.

ONCOGENE (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

DDX11-AS1 modulates DNA damage repair to enhance paclitaxel resistance of lung adenocarcinoma cells

Jianhong Liu et al.

Summary: The high expression of DDX11-AS1 in lung adenocarcinoma promotes cell proliferation and resistance to paclitaxel (PTX), while inhibiting cell apoptosis. Additionally, DDX11-AS1 expression modulates the DNA damage repairing ability.

PHARMACOGENOMICS (2023)

添加到收藏夹

Article Cell Biology

LncRNA LINC00969 promotes acquired gefitinib resistance by epigenetically suppressing of NLRP3 at transcriptional and posttranscriptional levels to inhibit pyroptosis in lung cancer

Jiali Dai et al.

Summary: Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment prolongs the survival of lung cancer patients with EGFR mutations, but resistance is common. LINC00969, a long non-coding RNA, is found to be elevated in lung cancer cells with gefitinib resistance. It regulates resistance to gefitinib by modifying histone and RNA methylation and suppressing key signaling pathways. These findings highlight LINC00969 as a potential biomarker and therapeutic target for overcoming EGFR-TKI resistance in lung cancer.

CELL DEATH & DISEASE (2023)

添加到收藏夹

Article Chemistry, Multidisciplinary

MIR497HG-Derived miR-195 and miR-497 Mediate Tamoxifen Resistance via PI3K/AKT Signaling in Breast Cancer

Yao Tian et al.

Summary: The deficiency of MIR497HG contributes to breast cancer progression and tamoxifen resistance by downregulating miR-497/195. miR-497/195 collectively represses five PI3K-AKT regulators, resulting in inhibition of PI3K-AKT signaling. Additionally, ERα binds to the MIR497HG promoter to activate its transcription in an estrogen-dependent manner. ZEB1 interacts with HDAC1/2 and DNMT3B at the MIR497HG promoter, leading to promoter hypermethylation and histone deacetylation.

ADVANCED SCIENCE (2023)

添加到收藏夹

Article Oncology

Oncogenic lncRNA BBOX1-AS1 promotes PHF8-mediated autophagy and elicits sorafenib resistance in hepatocellular carcinoma

Haisu Tao et al.

Summary: This study found that the lncRNA BBOX1-AS1 promotes tumor progression and drug resistance in HCC by upregulating PHF8. BBOX1-AS1 enhances the stability of PHF8 mRNA by targeting miR-361-3p, leading to tumor progression and autophagy. These findings suggest that BBOX1-AS1 promotes HCC progression and sorafenib resistance through the miR-361-3p/PHF8 axis.

MOLECULAR THERAPY-ONCOLYTICS (2023)

添加到收藏夹

Article Oncology

LncRNA ERVH48-1 Contributes to the Drug Resistance of Prostate Cancer and Proliferation through Sponging of miR-4784 to the Activation of the Wnt/β-Catenin Pathway

Binshen Chen et al.

Summary: Long noncoding RNAs (LncRNAs) are critical in the occurrence and development of prostate cancer. Drug resistance is a main obstacle in chemotherapy effectiveness, and various immunosuppressive mechanisms contribute to tumor immune evasion and drug resistance. This study identified lncRNAs related to cellular immunity and constructed a regulatory network to explore the mechanism of chemotherapy resistance in colon cancer cells.

CANCERS (2023)

添加到收藏夹

Article Pathology

DANCR Induces Cisplatin Resistance of Triple-Negative Breast Cancer by KLF5/p27 Signaling

Anchen Su et al.

Summary: A study identified DANCR, a long noncoding RNA, as a promoter of cisplatin chemoresistance in triple-negative breast cancer cells. It was found that DANCR binds to KLF5 and induces acetylation of KLF5, resulting in down-regulation of KLF5 and hypersensitivity to cisplatin through the DANCR/KLF5/p27 signaling pathway.

AMERICAN JOURNAL OF PATHOLOGY (2023)

添加到收藏夹

Article Biotechnology & Applied Microbiology

LncSNHG14 promotes nutlin3a resistance by inhibiting ferroptosis via the miR-206/SLC7A11 axis in osteosarcoma cells

Luoying Li et al.

Summary: Osteosarcoma (OS) is the most common primary osseous malignant tumor in adolescents and children. The standard therapy involves surgery combined with neoadjuvant/post-surgery chemotherapy, but chemoresistance often leads to poor efficacy. In this study, the upregulation of lncRNA SNHG14 was found to contribute to treatment resistance by suppressing ferroptosis in a nutlin3a-resistant OS cell line. Knockdown of lncRNA SNHG14 reversed drug resistance and activated ferroptosis, indicating its role in chemotherapy resistance and ferroptosis inhibition. Targeting lncRNA SNHG14 may provide a new approach to overcome drug resistance and improve treatment efficacy in osteosarcoma.

CANCER GENE THERAPY (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

LncRNA PRKCQ-AS1 regulates paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p/PIK3C3 mediated autophagy

Shurong Zheng et al.

Summary: The aim of this study is to investigate the effect and mechanism of lncRNA on the PTX resistance of TNBC cells through autophagy. Down-regulation of lncRNA PRKCQ-AS1 weakened PTX resistance and promoted cell apoptosis by miR-361-5p/PIK3C3 mediated autophagy.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

LncRNA NR2F1-AS1 was involved in azacitidine resistance of THP-1 cells by targeting IGF1 with miR-483-3p

Changmei Hu et al.

Summary: This study explored the mechanism of the lncRNA NR2F1-AS1/miR-483-3p/IGF1 axis in azacitidine resistance in THP-1 cells. The results showed that NR2F1-AS1 and IGF1 were highly expressed, while miR-483-3p expression was significantly decreased in THP1-Aza cells. NR2F1-AS1 affected the sensitivity of THP-1 cells to azacitidine resistance by regulating the miR-483-3p/IGF1 axis.

CYTOKINE (2023)

添加到收藏夹

Review Pharmacology & Pharmacy

Loss of cancer-associated fibroblast-derived exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer

Xianlin Qu et al.

Summary: In this study, a novel lncRNA called DACT3-AS1 was found to play a crucial role in gastric cancer (GC) by targeting the miR-181a-5p/SIRT1 axis to suppress cell proliferation, migration, and invasion. Additionally, DACT3-AS1 was transmitted from cancer-associated fibroblasts (CAFs) to GC cells via exosomes. Moreover, DACT3-AS1 enhanced the sensitivity of GC cells to oxaliplatin through SIRT1-mediated ferroptosis. Therefore, DACT3-AS1 may serve as a potential diagnostic and therapeutic target for GC.

DRUG RESISTANCE UPDATES (2023)

添加到收藏夹

Article Oncology

Induction of m6A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance

Zhiming Wang et al.

Summary: This study elucidates an unexplored mechanism of how the adipocyte-rich microenvironment exacerbates therapeutic resistance in multiple myeloma (MM) and indicates a potential strategy to improve therapeutic efficacy by blocking the exosome-mediated cycle.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Advances in Salmonella Typhimurium-based drug delivery system for cancer therapy

Wenfei Chen et al.

Summary: The clinical application of bacteria-mediated immune therapy has a long history and has greatly advanced in recent years. This review focuses on the bioengineered and functionalized Salmonella Typhimurium strains as drug delivery carriers, discussing the genetic circuits for programming these bacteria, surface modification strategies using nanoparticles or other therapeutic agents, and the potential of bacterial component-based vehicles for cancer immunotherapy. The promises and challenges of these optimized Salmonella-based delivery systems and their clinical trials are also discussed.

ADVANCED DRUG DELIVERY REVIEWS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Solid Tumors and Kinase Inhibition: Management and Therapy Efficacy Evolution

Flavia Melo Cunha de Pinho Pessoa et al.

Summary: The increasing numbers of cancer cases and high mortality rates of certain tumor subtypes lead to questioning the effectiveness of current cancer management protocols and efforts to improve patient prognoses. Traditional chemo-immunotherapy focuses on using cytotoxic agents and boosting the immune system, while precision medicine and targeted molecular therapies have gained interest for their specificity and positive clinical outcomes. This article presents clinical trials utilizing kinase inhibitors as monotherapy or in combination with other agents to treat solid tumors in the past 5 years, reporting varying levels of efficacy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Irbesartan decreased mitochondrial stress related apoptosis in cisplatin induced acute kidney injury via regulating BCL-2/BAX signaling

Ilter Ilhan et al.

Summary: This study aimed to evaluate the renoprotective effects of Irbesartan on cisplatin-induced acute kidney injury. The results showed that Irbesartan exerted anti-inflammatory and antioxidant activity by inhibiting mitochondrial stress, leading to significant regression of kidney damage.

MOLECULAR BIOLOGY REPORTS (2022)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Knockdown of lncRNA ACTA2-AS1 reverses cisplatin resistance of ovarian cancer cells via inhibition of miR-378a-3p-regulated Wnt5a

Chenxiao Lin et al.

Summary: This study investigates the role of lncRNA ACTA2-AS1 in ovarian cancer cells resistant to cisplatin. The findings suggest that ACTA2-AS1 acts as a sponge for miR-378a-3p, preventing its binding to Wnt5a and enhancing cisplatin resistance in ovarian cancer cells.

BIOENGINEERED (2022)

添加到收藏夹

Article Oncology

Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer

Wangkai Xie et al.

Summary: Pancreatic cancer is a leading cause of cancer death worldwide due to its lack of early symptoms, metastasis, and chemoresistance. This review article summarizes the role of long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) in modulating chemosensitivity in pancreatic cancer cells. It also highlights the potential compounds that can modulate the expression of lncRNAs and enhance chemosensitivity in pancreatic cancers.

SEMINARS IN CANCER BIOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Long non-coding RNA LINC01559 serves as a competing endogenous RNA accelerating triple-negative breast cancer progression

Xue Yang et al.

Summary: LINC01559 is significantly upregulated in TNBC tissues and acts as a carcinogenic ceRNA by sponging miRNAs, resulting in the increased expression of oncogenes and promoting TNBC progression. Targeting LINC01559 may be a potential treatment for TNBC patients.

BIOMEDICAL JOURNAL (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy

Fang Huang et al.

Summary: This article discusses the biological properties of NDV, the antitumor molecular mechanisms of oncolytic NDV, and its application in tumor therapy. Additionally, new insights are presented on the challenges that NDV will face and suggestions for increasing NDV's therapeutic efficacy in cancer.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Fusion of Tumor-Derived Exosomes with Long-Circulating and pH-Sensitive Liposomes Loaded with Doxorubicin for the Treatment of Breast Cancer

E. R. Gomes et al.

Summary: The purpose of this study was to fuse exosomes derived from breast tumor cells with long-circulating and pH-sensitive liposomes loading DOX (ExoSpHL-DOX) for the treatment of breast cancer. The physicochemical characteristics of ExoSpHL-DOX were maintained for 60 days and the release of DOX from ExoSpHL-DOX showed pH sensitivity. Results demonstrated that ExoSpHL-DOX treatment significantly reduced the cancer cell viability.

AAPS PHARMSCITECH (2022)

添加到收藏夹

Article Oncology

Exosomes deliver lncRNA DARS-AS1 siRNA to inhibit chronic unpredictable mild stress-induced TNBC metastasis

Xinli Liu et al.

Summary: TNBC is a highly metastatic malignancy with high heterogeneity and resistance to chemoradiotherapy. The CUMS-responsive lncRNA DARS-AS1 was found to be enriched in TNBC clinical tumors and cells, positively correlated with late clinical stage, and overexpression of DARS-AS1 enhanced migration and invasion of TNBC tumors. Treatment with DARS-AS1 siRNA-loaded exosomes slowed CUMS-induced TNBC cell growth and liver metastasis.

CANCER LETTERS (2022)

添加到收藏夹

Article Oncology

An Alternatively Spliced p62 Isoform Confers Resistance to Chemotherapy in Breast Cancer

Qianying Guo et al.

Summary: A novel p62 mRNA isoform that escapes miRNA-mediated repression and leads to increased p62 protein expression was found to be associated with chemoresistance in breast cancer cells and tissue specimens.

CANCER RESEARCH (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy

Mehrdad Hashemi et al.

Summary: Initiation and development of cancer depend on multiple factors including gene mutations and epigenetic changes. LncRNA H19, a non-coding RNA molecule, is found to be abnormally expressed in various cancers and contributes to tumor growth, metastasis and drug resistance. It has the potential to serve as a biomarker for poor prognosis and therapy response.

PHARMACOLOGICAL RESEARCH (2022)

添加到收藏夹

Article Cell & Tissue Engineering

LncRNA MALAT1 from human adipose-derived stem cell exosomes accelerates wound healing via miR-378a/FGF2 axis

Li Pi et al.

Summary: This study investigates the effects of MALAT1 from human adipose-derived stem cell (ADSC) exosomes on skin wound healing. The results showed that ADSC exosomes promoted the proliferation and migration of human skin fibroblasts (HSFs) and increased MALAT1 expression. MALAT1 silencing inhibited HSF viability and migration, promoted apoptosis, and suppressed angiogenesis by upregulating miR-378a. Overexpression of miR-378a inhibited HSF migration and proliferation by downregulating FGF2 expression. Exosomal MALAT1 accelerated skin wound healing by mediating the miR-378a/FGF2 axis.

REGENERATIVE MEDICINE (2022)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Exosomes in the tumor microenvironment of sarcoma: from biological functions to clinical applications

Huali Ye et al.

Summary: Exosomes play an important role in the tumor microenvironment of sarcoma, promoting cancer progression and metastasis through mediating cellular communications. Due to their unique characteristics, exosomes are regarded as potential biomarkers and vehicles for diagnosis and treatment of sarcoma.

JOURNAL OF NANOBIOTECHNOLOGY (2022)

添加到收藏夹

Review Genetics & Heredity

Roles and regulation of histone acetylation in hepatocellular carcinoma

Jin-kun Xia et al.

Summary: Hepatocellular Carcinoma (HCC) is a common malignant liver tumor with a poor prognosis. Histone acetylation, a crucial epigenetic regulatory mode, plays a role in controlling gene expression in eukaryotic cells. Dysregulation of histone modification is implicated in the development of liver cancer. Some HDAC inhibitors have shown tumor-suppressive properties by activating cell death pathways in HCC.

FRONTIERS IN GENETICS (2022)

添加到收藏夹

Review Cell Biology

Functions and underlying mechanisms of lncRNA HOTAIR in cancer chemotherapy resistance

Chunming Zhu et al.

Summary: Chemotherapy is a significant treatment for advanced cancer, but drug-resistant tumors often relapse. The homeobox transcript antisense intergenic RNA (HOTAIR) has been found to play a role in tumor development and is associated with chemotherapy resistance. Therefore, understanding the biology and mechanism of HOTAIR in tumor behavior and its potential as a biomarker for predicting chemotherapy efficacy is crucial.

CELL DEATH DISCOVERY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancer

Ye Li et al.

Summary: Tumor-derived exosomes (TDEs) play critical roles in tumor development and progression, as well as resistance to cancer drugs and immunotherapy. Inhibiting or removing TDEs can improve cancer therapies.

EXPERIMENTAL AND MOLECULAR MEDICINE (2022)

添加到收藏夹

Article Oncology

Intermittent fasting during adjuvant chemotherapy may promote differential stress resistance in breast cancer patients

Enas M. Omar et al.

Summary: This study found that intermittent fasting (IF) can reduce the toxicity of chemotherapy in breast cancer patients during adjuvant chemotherapy. Hematologic parameters showed no significant variations, but the glucose and insulin levels increased in the non-fasting group. The IF group showed a decrease in insulin levels. Therefore, IF can improve patients' metabolic profiles and may have a positive impact on the clinical efficacy of chemotherapy.

JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Overexpression of lncRNA HCP5 in human umbilical cord mesenchymal stem cell-derived exosomes promoted the proliferation and inhibited the apoptosis of ovarian granulosa cells via the musashi RNA-binding protein 2/oestrogen receptor alpha 1 axis

Yu-Ting Sun et al.

Summary: This study found that HCP5 and hucMSCs-exo play important roles in promoting ovarian granulosa cell proliferation and inhibiting cell apoptosis. HCP5 targeted MSI2, leading to increased expression of ESR1 and enhanced proliferation of OGCs.

ENDOCRINE JOURNAL (2022)

添加到收藏夹

Review Oncology

Role and mechanism of autophagy-regulating factors in tumorigenesis and drug resistance

Rana Muhammad Usman et al.

Summary: Autophagy is regulated by multiple genes and plays a crucial role in tumorigenesis and drug resistance. Disrupted autophagy is associated with various malignancies, affecting cell growth and treatment response. Therapeutic approaches targeting autophagy may provide new strategies for cancer drug development and overcoming drug resistance.

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Exosomal lncRNA FOXD3-AS1 upregulates ELAVL1 expression and activates PI3K/Akt pathway to enhance lung cancer cell proliferation, invasion, and 5-fluorouracil resistance

Guangxian Mao et al.

Summary: In this study, we found that FOXD3-AS1 is upregulated in lung cancer tissues and cell lines, and enriched in lung cancer cell-derived exosomes. FOXD3-AS1 activates the PI3K/Akt pathway to promote lung cancer progression, providing a potential new strategy for lung cancer treatment.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2021)

添加到收藏夹

Article Oncology

Landmark Series: Immunotherapy and Targeted Therapy for Pancreatic Cancer

Flavio G. Rocha

Summary: Pancreatic cancer is an aggressive gastrointestinal malignancy, and recent genomic studies have identified key driver mutations that can be targeted for therapy. Advances in cancer immunology have also shown potential for utilizing the host's immune system for treatment. However, the unique fibrotic stroma of pancreatic cancer presents challenges in translating these strategies to clinical practice.

ANNALS OF SURGICAL ONCOLOGY (2021)

添加到收藏夹

Review Pharmacology & Pharmacy

Multidrug resistance proteins (MRPs): Structure, function and the overcoming of cancer multidrug resistance

Jing-Quan Wang et al.

Summary: ABC transporters mediate the translocation of structurally and mechanistically distinct substrates against steep concentration gradients using ATP energy. The ABCC subfamily is the largest in humans, with 13 members, including 9 multidrug resistance proteins that can extrude chemotherapeutic agents from tumor cells. Additionally, MRPs are also involved in the efflux of physiologically important organic anions and are potential targets for overcoming cancer multidrug resistance.

DRUG RESISTANCE UPDATES (2021)

添加到收藏夹

Article Toxicology

Identification of potential novel drug resistance mechanisms by genomic and transcriptomic profiling of colon cancer cells with p53 deletion

Onat Kadioglu et al.

Summary: In this study, colon cancer cells with TP53 deletion were characterized, and multiple genes were found to be overexpressed, potentially influencing multidrug resistance. The research sheds light on unknown drug resistance mechanisms and may impact future treatment strategies.

ARCHIVES OF TOXICOLOGY (2021)

添加到收藏夹

Review Medicine, Research & Experimental

The role of non-coding RNAs in chemotherapy for gastrointestinal cancers

Fatemeh Dashti et al.

Summary: Chemoresistance is a major challenge in treating advanced GI cancers, with non-coding RNAs playing a critical role in inducing resistance by affecting multiple signaling pathways and gene expression regulation.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

添加到收藏夹

Article Oncology

HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer

Weiting Li et al.

Summary: HOTAIR is upregulated in gefitinib-resistant lung cancer cells, enhancing resistance to the drug. Through regulation of EZH2 and p16, p21, it influences cell cycle progression and drug resistance in lung cancer. Targeting HOTAIR may be a novel therapeutic strategy for treating gefitinib resistance in non-small cell lung cancer.

JOURNAL OF CANCER (2021)

添加到收藏夹

Article Medicine, Research & Experimental

ATP-triggered mitochondrial cascade reactions for cancer therapy with nanoscale zeolitic imidazole framework-90

Wei Pan et al.

Summary: The utilization of ATP-triggered strategy with nanoscale ZIF-90 to initiate mitochondrial cascade reactions for cancer therapy is crucial, leading to continuous oxidative stress and apoptosis of cancer cells.

THERANOSTICS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

EMT imparts cancer stemness and plasticity: new perspectives and therapeutic potential

Sayoni Roy et al.

Summary: Epithelial-to-mesenchymal transition (EMT) is a crucial cellular process in development, tissue repair, and cancer progression, regulated by transcription factors, cytokines, and growth factors. Recent studies highlight the significance of cancer stem cells (CSCs) in tumor promotion, invasion, and metastasis.

FRONTIERS IN BIOSCIENCE-LANDMARK (2021)

添加到收藏夹

Article Obstetrics & Gynecology

Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells

Chencheng Dai et al.

Summary: The study revealed that ZEB1-AS1 plays a pivotal role in cancer chemoresistance by regulating MMP19, providing a potential target for overcoming drug resistance in ovarian cancer cells.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2021)

添加到收藏夹

Article Oncology

Long noncoding RNA CCAL transferred from fibroblasts by exosomes promotes chemoresistance of colorectal cancer cells

Xuan Deng et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis

Mengnuo Chen et al.

MOLECULAR CANCER (2020)

添加到收藏夹

Article Oncology

Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis

Huasong Liu et al.

ONCOLOGY RESEARCH (2020)

添加到收藏夹

Review Oncology

Overcoming Endocrine Resistance in Breast Cancer

Ariella B. Hanker et al.

CANCER CELL (2020)

添加到收藏夹

Article Medicine, Research & Experimental

lncRNA PVT1/MicroRNA-17-5p/PTEN Axis Regulates Secretion of E2 and P4, Proliferation, and Apoptosis of Ovarian Granulosa Cells in PCOS

Gelin Liu et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Mechanisms of Multidrug Resistance in Cancer Chemotherapy

Karol Bukowski et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

lncRNA UCA1 Contributes to 5-Fluorouracil Resistance of Colorectal Cancer Cells Through miR-23b-3p/ZNF281 Axis

Zhenyu Xian et al.

ONCOTARGETS AND THERAPY (2020)

添加到收藏夹

Article Cell Biology

Exosomal lncRNA HEIH promotes cisplatin resistance in tongue squamous cell carcinoma via targeting miR-3619-5p/HDGF axis

Xiaowei Wang et al.

ACTA HISTOCHEMICA (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance

Nuray Erin et al.

DRUG RESISTANCE UPDATES (2020)

添加到收藏夹

Article Oncology

LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway

Qingqiang Dai et al.

JOURNAL OF CANCER (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer

Elizabeth L. Christie et al.

NATURE COMMUNICATIONS (2019)

添加到收藏夹

Review Medicine, Research & Experimental

UCA1 long non-coding RNA: An update on its roles in malignant behavior of cancers

Soudeh Ghafouri-Fard et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

添加到收藏夹

Article Cell Biology

LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis

Meng Wu et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Analyzing the Interactions of mRNAs and ncRNAs to Predict Competing Endogenous RNA Networks in Osteosarcoma Chemo-Resistance

Kun-Peng Zhu et al.

MOLECULAR THERAPY (2019)

添加到收藏夹

Review Cell Biology

New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer

Anushka Dongre et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

添加到收藏夹

Article Pathology

Effects of long noncoding RNA (linc-VLDLR) existing in extracellular vesicles on the occurrence and multidrug resistance of esophageal cancer cells

YueTong Chen et al.

PATHOLOGY RESEARCH AND PRACTICE (2019)

添加到收藏夹

Article Medicine, Research & Experimental

LncRNA-MALAT1 contributes to the cisplatin-resistance of lung cancer by upregulating MRP1 and MDR1 via STAT3 activation

Zhixian Fang et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Long noncoding RNA FOXD2-AS1 accelerates the gemcitabine-resistance of bladder cancer by sponging miR-143

Qing An et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

The long non-coding RNA SNHG5 regulates gefitinib resistance in lung adenocarcinoma cells by targetting miR-377/CASP1 axis

ZheXing Wang et al.

BIOSCIENCE REPORTS (2018)

添加到收藏夹

Article Oncology

LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1

Zhi-wei Chang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Long noncoding RNA LUCAT1 promotes malignancy of ovarian cancer through regulation of miR-612/HOXA13 pathway

He Yu et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

添加到收藏夹

Article Cell Biology

lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1

Chuan He et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)

添加到收藏夹

Article Cell Biology

被撤回的出版物: Long non-coding RNA SNHG14 induces trastuzumab resistance of breast cancer via regulating PABPC1 expression through H3K27 acetylation (Retracted article. See vol. 42, 2023)

Huaying Dong et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)

添加到收藏夹

Article Oncology

被撤回的出版物: Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA (Retracted article. See vol. 42, 2023)

Min Kang et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

添加到收藏夹

Article Medicine, Research & Experimental

lncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221/SOCS3 in Pancreatic Cancer

Bingyan Liu et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2018)

添加到收藏夹

Article Oncology

Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity in bladder cancer cells

S. Q. Feng et al.

NEOPLASMA (2018)

添加到收藏夹

Article Oncology

Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression

Lei Pan et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2017)

添加到收藏夹

Article Oncology

miR-432 Induces NRF2 Stabilization by Directly Targeting KEAP1

Burak Akdemir et al.

MOLECULAR CANCER RESEARCH (2017)

添加到收藏夹

Review Oncology

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

Tsukasa Shibue et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

Exosomes: Therapy delivery tools and biomarkers of diseases

Lucio Barile et al.

PHARMACOLOGY & THERAPEUTICS (2017)

添加到收藏夹

Article Oncology

Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression

Huijuan Jiang et al.

RADIATION ONCOLOGY (2017)

添加到收藏夹

Article Medicine, Research & Experimental

Kanglaite inhibits the expression of drug resistance genes through suppressing PVT1 in cisplatin-resistant gastric cancer cells

Xian-Wen Zhang et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)

添加到收藏夹

Article Oncology

Long noncoding RNA ROR regulates chemoresistance in docetaxel-resistant lung adenocarcinoma cells via epithelial mesenchymal transition pathway

Yan Pan et al.

ONCOTARGET (2017)

添加到收藏夹

Article Cell Biology

The Novel Long Noncoding RNA TUSC7 Inhibits Proliferation by Sponging MiR-211 in Colorectal Cancer

Jian Xu et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

添加到收藏夹

Review Medicine, Research & Experimental

Regulatory players of DNA damage repair mechanisms: Role in Cancer Chemoresistance

Kunnathur Murugesan Sakthivel et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

添加到收藏夹

Article Oncology

Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205

Hong-Yan Zhang et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer

X. Xue et al.

ONCOGENE (2016)

添加到收藏夹

Article Oncology

Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer

Jing Li et al.

TUMOR BIOLOGY (2016)

添加到收藏夹

Article Oncology

Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation

Xinxing Li et al.

BMC CANCER (2016)

添加到收藏夹

Article Oncology

Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA

Le Qu et al.

CANCER CELL (2016)

添加到收藏夹

Article Oncology

High TUG1 expression is associated with chemotherapy resistance and poor prognosis in esophageal squamous cell carcinoma

Lin Jiang et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)

添加到收藏夹

Article Biochemistry & Molecular Biology

NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer

A. R. Ozes et al.

ONCOGENE (2016)

添加到收藏夹

Article Oncology

Genome-wide profiling of long non-coding RNA expression patterns in the EGFR-TKI resistance of lung adenocarcinoma by microarray

Ying Wu et al.

ONCOLOGY REPORTS (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer

Angel Diaz-Lagares et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

添加到收藏夹

Review Immunology

Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer

Paul E. Hughes et al.

TRENDS IN IMMUNOLOGY (2016)

添加到收藏夹

Article Neurosciences

Long Non-coding RNA TUSC7, a Target of miR-23b, Plays Tumor-Suppressing Roles in Human Gliomas

Chao Shang et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2016)

添加到收藏夹

Article Multidisciplinary Sciences

LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p

Zehua Bian et al.

SCIENTIFIC REPORTS (2016)

添加到收藏夹

Article Oncology

Reciprocal repression between TUSC7 and miR-23b in gastric cancer

Peng Qi et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

添加到收藏夹

Article Oncology

LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer

Sheng-Jia Shi et al.

ONCOTARGET (2015)

添加到收藏夹

Article Oncology

LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition

Yuehua Han et al.

BMC CANCER (2014)

添加到收藏夹

Article Oncology

Involvement of Extracellular Vesicle Long Noncoding RNA (linc-VLDLR) in Tumor Cell Responses to Chemotherapy

Kenji Takahashi et al.

MOLECULAR CANCER RESEARCH (2014)

添加到收藏夹

Article Genetics & Heredity

Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters

Tiffany Hung et al.

NATURE GENETICS (2011)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.